Thiazide diuretics and the risk of osteoporotic fractures in hypertensive patients. Results from the Swedish Primary Care Cardiovascular Database

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Hypertension

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/HJH.0000000000001124PMID 27749388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased Bone Mineral Density Is an Independent Predictor for the Development of Atherosclerosis: A Systematic Review and Meta-Analysis

  2016cited by this paper
• Continuous and long‐term treatment is more important than dosage for the protective effect of thiazide use on bone metabolism and fracture risk

  2016cited by this paper
• Modeling Survival Data Extending The Cox Model

  2016cited by this paper
• Thiazide‐Sensitive Na+‐Cl− Cotransporter (NCC) Gene Inactivation Results in Increased Duodenal Ca2+ Absorption, Enhanced Osteoblast Differentiation and Elevated Bone Mineral Density

  2015cited by this paper
• Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs – Overview and meta-analyses

  2015cited by this paper
• Association of age-dependent height and bone mineral density decline with increased arterial stiffness and rate of fractures in hypertensive individuals

  2015cited by this paper
• Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD).

  2014cited by this paper
• Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults.

  2014cited by this paper
• The Swedish Primary Care Cardiovascular Database (SPCCD): 74 751 hypertensive primary care patients

  2014cited by this paper
• 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension

  2014cited by this paper
• Osteoporosis in the European Union: medical management, epidemiology and economic burden

  2013cited by this paper
• Association between hypertension and fragility fracture: a longitudinal study

  2013cited by this paper
• Diuretic initiation and the acute risk of hip fracture

  2013cited by this paper
• Antihypertensive drugs and the risk of fall injuries: A systematic review and meta-analysis

  2013cited by this paper
• A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

  2012cited by this paper
• The risk of hip fracture after initiating antihypertensive drugs in the elderly.

  2012cited by this paper
• Thiazide diuretics and the risk of hip fracture.

  2011cited by this paper
• Epithelial Na+ Channel (ENaC), Hormones, and Hypertension*

  2010cited by this paper
• Hypertension Is a Risk Factor for Fractures

  2009cited by this paper
• Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone.

  2007cited by this paper
• 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension

  2007cited by this paper
• The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

  2007cited by this paper
• The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women

  2007cited by this paper
• Effects of antihypertensive drug treatments on fracture outcomes: a meta‐analysis of observational studies

  2006cited by this paper
• Reduced Fracture Risk in Users of Thiazide Diuretics

  2005cited by this paper
• A prospective study of thiazide use and fractures in women

  2005cited by this paper
• A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women

  2005cited by this paper
• Osteoporosis and cardiovascular disease

  2004cited by this paper
• Thiazide Diuretics and the Risk for Hip Fracture

  2003cited by this paper
• Increased bone mineral density in a population‐based group of 70‐year‐old women on thiazide diuretics, independent of parathyroid hormone levels

  2001cited by this paper
• Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults

  2000cited by this paper
• Current use of thiazide diuretics and prevention of femur fractures.

  1996cited by this paper
• Thiazide diuretics and fractures: Can meta‐analysis help?

  1995cited by this paper
• Thiazides and bone mineral density in elderly men and women.

  1994cited by this paper
• Psychotropics, thiazide diuretics and hip fractures in the elderly

  1993cited by this paper
• Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

  1993cited by this paper
• Effects of Thiazide Diuretic Therapy on Bone Mass, Fractures, and Falls

  1993cited by this paper
• Thiazide diuretic agents and prevention of hip fracture.

  1991cited by this paper
• Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study.

  1991cited by this paper
• Thiazide diuretic agents and prevention of hip fracture.

  1991cited by this paper
• Diuretic drug use and the risk for hip fracture.

  1991cited by this paper
• Effect of thiazide on rates of bone mineral loss: a longitudinal study.

  1990cited by this paper
• Long-term use of thiazide diuretics and risk of hip fracture.

  1989cited by this paper
• Thiazide for the postponement of postmenopausal bone loss.

  1982cited by this paper
• Improvement of renal function with prostaglandin E1 infusion in patients with chronic renal disease.

  1974cited by this paper

• Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care

  2023cites this paper
• Effects of bendroflumethiazide on bone mineral density; results from the BONATHIAD randomized double-blind placebo-controlled cohort study

  2020cites this paper
• Improvement on Hypertension Management with Pharmacological and Non-Pharmacological Approaches: Current Perspectives.

  2020cites this paper
• The impact of thiazide diuretics on bone mineral density and the trabecular bone score: The Rotterdam study.

  2020cites this paper
• Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database.

  2019cites this paper
• Thiazide Diuretics and the Incidence of Osteoporotic Fracture: A Systematic Review and Meta-Analysis of Cohort Studies

  2019influential citation
• Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis

  2019cites this paper
• Clinical Update on Osteoporosis.

  2019cites this paper
• Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer’s disease—nested case-control study

  2019cites this paper
• Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies

  2018cites this paper
• Thiazide diuretic as an antihypertensive agent for patients with osteoporosis.

  2018cites this paper
• Prevention and Treatment

  2018cites this paper
• Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation

  2018cites this paper
• Calibration of SphygmoCor.

  2017cites this paper
• Thiazide diuretics and fracture in patients with hypertension.

  2017cites this paper
• The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk

  2017cites this paper
• Data and text mining Design and application of a knowledge network for automatic prioritization of drug mechanisms

  year unknowncites this paper